The current focus for disease management against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is vaccination. However, rapid diagnosis of variants is still pivotal for...
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic in late 2019, the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) such as the Alpha, Beta, Gamma, Delta, and Omicron variants, have been reported...
In a new study in the journal Accounts of Materials Research, researchers presented an overview of the recent advances in severe acute respiratory syndrome...
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been one of the greatest public health challenges worldwide....
AMSBIO has expanded its range of custom gene editing services to complement its extensive portfolio of off-the-shelf CRISPR/Cas9 products. Image Credit: AMS Biotechnology A powerful...
The current coronavirus disease 2019 (COVID-19) pandemic is caused by the global circulation of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is highly...
In a recent study posted to the bioRxiv* pre-print server, researchers performed high-throughput evolutionary analyses of genes encoding 334 severe acute respiratory syndrome coronavirus 2...
A recent review in the Chemical and Pharmaceutical Bulletin looks at the molecular design of pH-sensitive cationic lipids and their applications for various tissues and...
